|
Results of a randomized, double-blind placebo-controlled phase 3 study evaluating idelalisib in combination with bendamustine and rituximab in patients with relapsed/refractory CLL and adverse prognostic features. |
|
Jacqueline Claudia Barrientos |
Consulting or Advisory Role - Celgene; Genentech; Pharmacyclics |
Research Funding - Abbvie; Gilead Sciences |
|
|
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; ProNAi; Roche/Genentech; Sun Pharma |
|
|
Research Funding - Gilead Sciences |
|
|
Stock and Other Ownership Interests - Pharmacyclics (I) |
Consulting or Advisory Role - Abbvie; Celgene; Genentech/Roche; Gilead Sciences; Novartis; Pharmacyclics |
Research Funding - Abbvie (Inst); Celgene (Inst); Gilead Sciences (Inst); Novartis (Inst); Pharmacyclics (Inst) |
Travel, Accommodations, Expenses - abbvie; Celgene; Gilead Sciences; Novartis; Pharmacyclics |
|
|
Research Funding - Gilead Sciences |
|
|
Research Funding - Gilead Sciences; Idera |
|
|
Honoraria - Celgene; Janssen; Pharmacyclics |
Consulting or Advisory Role - Celgene; Genentech |
Speakers' Bureau - Celgene; Genentech; Gilead Sciences; Janssen; Pharmacyclics |
Research Funding - Gilead Sciences |
|
|
Research Funding - Gilead Sciences |
|
|
Research Funding - Gilead Sciences |
|
|
Honoraria - Gilead Sciences; Janssen |
Consulting or Advisory Role - Takeda |
Research Funding - Gilead Sciences |
|
|
No Relationships to Disclose |
|
|
Employment - Gilead Sciences |
Stock and Other Ownership Interests - Gilead Sciences |
|
|
Employment - Gilead Sciences |
Stock and Other Ownership Interests - Gilead Sciences |
|
|
Employment - Gilead Sciences |
Stock and Other Ownership Interests - Gilead Sciences |
|
|
Employment - Gilead Sciences |
Stock and Other Ownership Interests - Gilead Sciences |
|
|
Stock and Other Ownership Interests - Adaptive Biotechnologies |
Consulting or Advisory Role - Alissa Pharma; Alphasights; Amgen; Celgene; Genentech/Roche; Gilead Sciences; Hospira |
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Gilead Sciences |
Travel, Accommodations, Expenses - Celgene; Kirin Pharmaceuticals |
Other Relationship - Boehringer Ingelheim; Quintiles |
|
|
Research Funding - Gilead Sciences |